Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01811654 · ClinicalTrials.gov registry record · NA
Effectiveness Trial for Evaluating IAHA for PFPS
A NA study, sponsored by NYU Langone Health.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
NCT01811654 is a NA study that has completed, run by NYU Langone Health. The registered enrollment target is 30 participants.
The verdict
NCT01811654, a NA study, has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the safety and effectiveness of intra-articular hyaluronan (IAHA) injections for the treatment of symptomatic patellofemoral pain syndrome (PFPS) and determine if this treatment can provide incremental clinical benefits over standard care for patients with this diagnosis.
Interventions
- DEVICE Intra-Articular Hyaluronic Acid-Euflexxa
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2013-04 |
| Est. Completion | 2017-03-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01811654
The ClinicalTrials.gov registry entry for NCT01811654 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Intra-Articular Hyaluronic Acid-Euflexxa is the first listed.
NCT01811654 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01811654 about?
NCT01811654 is a clinical study titled "Effectiveness Trial for Evaluating IAHA for PFPS". The purpose of this study is to determine the safety and effectiveness of intra-articular hyaluronan (IAHA) injections for the treatment of symptomatic patellofemoral pain syndrome (PFPS) and determine if this treatment can provide incremental clinical benefits over standard care for patients with t...
What is the current status of trial NCT01811654?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2013-04. Estimated completion is 2017-03-04.
What interventions are being tested in trial NCT01811654?
The interventions under investigation include: Intra-Articular Hyaluronic Acid-Euflexxa (DEVICE).
Who is sponsoring clinical trial NCT01811654?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.